Follow this preprint
Humans with Pulmonary Arterial Hypertension display a global hypermethylation signature that worsens in patients who have a mutation in the gene encoding the methylation eraser, Tet Methylcytosine Dioxygenase 2 (TET2)
Charles C.T Hindmarch, François Potus, Al-Qazazi Ruaa, Brooke Ring, William C Nichols, Michael J Rauh, Stephen L Archer
doi: https://doi.org/10.1101/2023.08.09.23293846
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Charles C.T Hindmarch
1Department of Biomedical and Molecular Science (DBMS), Queen’s University, Kingston, Ontario
2Department of Medicine, Queen’s University, Kingston, Ontario
3Queen’s CardioPulmonary Unit, Translational Institute of Medicine, Department of Medicine, Queen’s University, Kingston, Ontario, Canada
François Potus
4Pulmonary Hypertension Research Group, Center de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, QC, Canada
Al-Qazazi Ruaa
2Department of Medicine, Queen’s University, Kingston, Ontario
Brooke Ring
3Queen’s CardioPulmonary Unit, Translational Institute of Medicine, Department of Medicine, Queen’s University, Kingston, Ontario, Canada
William C Nichols
5Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, and Department of Pediatrics; University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Michael J Rauh
6Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Stephen L Archer
2Department of Medicine, Queen’s University, Kingston, Ontario
3Queen’s CardioPulmonary Unit, Translational Institute of Medicine, Department of Medicine, Queen’s University, Kingston, Ontario, Canada

Data Availability
Aggregate data can be shared with researchers at established Universities or Medical schools upon request.
Posted August 13, 2023.
Humans with Pulmonary Arterial Hypertension display a global hypermethylation signature that worsens in patients who have a mutation in the gene encoding the methylation eraser, Tet Methylcytosine Dioxygenase 2 (TET2)
Charles C.T Hindmarch, François Potus, Al-Qazazi Ruaa, Brooke Ring, William C Nichols, Michael J Rauh, Stephen L Archer
medRxiv 2023.08.09.23293846; doi: https://doi.org/10.1101/2023.08.09.23293846
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (418)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3181)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13157)
- Forensic Medicine (18)
- Gastroenterology (880)
- Genetic and Genomic Medicine (4994)
- Geriatric Medicine (460)
- Health Economics (765)
- Health Informatics (3145)
- Health Policy (1116)
- Hematology (418)
- HIV/AIDS (989)
- Medical Education (463)
- Medical Ethics (122)
- Nephrology (512)
- Neurology (4741)
- Nursing (252)
- Nutrition (702)
- Oncology (2438)
- Ophthalmology (692)
- Orthopedics (273)
- Otolaryngology (335)
- Pain Medicine (316)
- Palliative Medicine (89)
- Pathology (525)
- Pediatrics (1266)
- Primary Care Research (539)
- Public and Global Health (7307)
- Radiology and Imaging (1641)
- Respiratory Medicine (955)
- Rheumatology (468)
- Sports Medicine (411)
- Surgery (528)
- Toxicology (66)
- Transplantation (226)
- Urology (196)